| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,919 |
10,590 |
$491K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,596 |
1,084 |
$72K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,951 |
1,261 |
$49K |
| 80305 |
|
5,035 |
4,141 |
$39K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,156 |
819 |
$32K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
318 |
277 |
$16K |
| 99215 |
Prolong outpt/office vis |
71 |
56 |
$8K |
| 99384 |
|
163 |
77 |
$7K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
117 |
72 |
$6K |
| 99205 |
Prolong outpt/office vis |
36 |
36 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
592 |
230 |
$5K |
| 99490 |
Ccm add 20min |
709 |
676 |
$5K |
| 99382 |
|
138 |
54 |
$4K |
| 99383 |
|
70 |
29 |
$3K |
| 92551 |
|
649 |
304 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
64 |
56 |
$2K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
33 |
18 |
$2K |
| 90756 |
|
94 |
82 |
$773.14 |
| 36415 |
Collection of venous blood by venipuncture |
331 |
302 |
$764.89 |
| 99173 |
|
813 |
404 |
$665.79 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
26 |
18 |
$657.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
71 |
59 |
$609.38 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
87 |
55 |
$476.05 |
| 96127 |
|
312 |
159 |
$464.19 |
| 90674 |
|
53 |
52 |
$453.13 |
| Q2037 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) |
52 |
49 |
$283.04 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
21 |
15 |
$178.10 |
| 81025 |
|
16 |
14 |
$79.51 |
| 85018 |
|
194 |
73 |
$78.55 |
| 99406 |
|
13 |
12 |
$64.40 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
29 |
15 |
$42.04 |
| 36416 |
|
196 |
74 |
$3.20 |
| G0008 |
Administration of influenza virus vaccine |
101 |
98 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
53 |
49 |
$0.00 |